CHARLES RIV LABS INTL INC shareholders Q2 2023

CHARLES RIV LABS INTL INC's ticker is CRL and the CUSIP is 159864107. A total of 605 filers reported holding CHARLES RIV LABS INTL INC in Q2 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

CHARLES RIV LABS INTL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Daventry Group, LP 71,623$15,058,73611.15%
Laurus Investment Counsel Inc. 70,408$19,617,3097.04%
Soleus Capital Management, L.P. 209,496$44,046,5344.90%
M.D. Sass, Inc. 175,459$36,890,2554.89%
Jackson Square Partners, LLC 591,241$124,308,4203.62%
Future Fund LLC 1,755$368,9893.51%
LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE 55,162$11,597,8112.78%
Mudita Advisors LLP 15,000$3,153,7502.41%
MADDEN SECURITIES Corp 19,610$4,123,0032.11%
Ariel Investments 1,047,840$220,308,3612.09%
Community Capital Management, LLC 7,000$1,471,7502.04%
MONTRUSCO BOLTON INVESTMENTS INC. 629,825$130,536,4152.02%
PROFESSIONAL ADVISORY SERVICES INC 59,545$12,5191.90%
Premier Fund Managers Ltd 220,000$46,0021.83%
Southpoint Capital Advisors LP 400,000$84,100,0001.82%
NORRIS PERNE & FRENCH LLP/MI 102,813$21,616,4691.82%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 124,360$26,146,6901.74%
J.P. Marvel Investment Advisors, LLC 38,802$8,158,1211.70%
Bell Asset Management Ltd 45,904$9,651,3161.65%
LAKEWOOD CAPITAL MANAGEMENT, LP 87,740$18,447,3351.60%
About CHARLES RIV LABS INTL INC

Charles River Laboratories International Inc. is a leading provider of research products and services to the pharmaceutical, biotechnology, and medical device industries. The company has a global presence, with operations in North America, Europe, and Asia-Pacific.

Charles River Laboratories International Inc. offers a wide range of services, including drug discovery and development, safety assessment, and clinical support services. The company's expertise in these areas has made it a trusted partner for many of the world's leading pharmaceutical and biotechnology companies.

One of the key strengths of Charles River Laboratories International Inc. is its commitment to innovation. The company invests heavily in research and development, and has a track record of developing new products and services that meet the evolving needs of its customers.

Another important factor in the company's success is its focus on quality. Charles River Laboratories International Inc. has a rigorous quality control system in place, which ensures that its products and services meet the highest standards of safety and efficacy.

Overall, Charles River Laboratories International Inc. is a well-respected and highly regarded company in the pharmaceutical and biotechnology industries. Its commitment to innovation and quality has helped it to maintain a leading position in these markets, and it is well positioned to continue to grow and succeed in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists CHARLES RIV LABS INTL INC's shareholders in Q2 2023. To view CHARLES RIV LABS INTL INC's shareholder history, click here.